Ετικέτες

Δευτέρα 9 Απριλίου 2018

Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).

Author: Giugliano, Robert P. MD, SM; Cannon, Christopher P. MD; Blazing, Michael A. MD; Nicolau, Jose C. MD; Corbalan, Ramon MD; Spinar, Jindrich MD; Park, Jeong-Gun PhD; White, Jennifer A. MS; Bohula, Erin A. MD, DPhil; Braunwald, Eugene MD; On behalf of the IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial) Investigators
Page: 1571-1582


https://ift.tt/2HnOcDb

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αναζήτηση αυτού του ιστολογίου